BackNatureWise Biotech & Medicals Overview

NatureWise Biotech & Medicals Current Cash

Latest current cash for 4732.TWO: $130M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$127.05M
↓ 8.85% YoYΔ $-12.34M vs prior year quarter

Peer trimmed avg / median

Loading

NatureWise Biotech & Medicals Current Cash History

Loading

NatureWise Biotech & Medicals vs. peers: Current Cash Comparison

Loading

NatureWise Biotech & Medicals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NatureWise Biotech & Medicals (4732.TWO) FAQ

As of the most recent data (June 2026), 4732.TWO shows a current cash of $130M. That compares with $140M in the prior-year period — down 8.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4732.TWO's current cash is now $130M (was $140M) — a 8.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NatureWise Biotech & Medicals is outperforming or lagging.

Tracking 4732.TWO's current cash over time shows whether NatureWise Biotech & Medicals is scaling, shrinking, or reshaping that part of the business. The current reading is $130M That compares with $140M in the prior-year period — down 8.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has NatureWise Biotech & Medicals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $130M) with ownership activity and broader fundamentals.

NatureWise Biotech & Medicals's current cash is $130M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.